Business Context and Reporting Period
This Form 8-K is a current report filed by Imprimis Pharmaceuticals, Inc. (not Harrow, Inc.) on May 12, 2015. The filing details the results of the company's 2015 Annual Meeting of Stockholders held on the same date in San Diego, California.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The report discloses the final voting outcomes for two proposals:
- Proposal 1 (Election of Directors): All five nominees were elected.
- Stephen G. Austin: 4,776,301 For / 67,524 Withheld
- Mark L. Baum: 4,824,105 For / 19,720 Withheld
- Richard L. Lindstrom: 4,796,021 For / 47,804 Withheld
- Robert J. Kammer: 4,748,156 For / 95,669 Withheld
- William H. Nelson: 4,776,301 For / 67,524 Withheld
- Proposal 2 (Ratification of Auditors): The selection of KMJ Corbin and Company, LLP as the independent registered public accounting firm was ratified unanimously.
- For: 4,843,825
- Against: 0
- Abstain: 0
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Important Facts for Investors to Verify
- Confirm the company name is Imprimis Pharmaceuticals, Inc., as the metadata reference to "Harrow, Inc." appears to be incorrect based on the filing content.
- Verify the total number of shares outstanding to calculate the percentage of votes cast for each director.
- Review the full proxy statement for details on the director nominees' qualifications and the rationale for the auditor selection.